RECOUNT

In the UK, there are over 2.5 million undiagnosed neurodivergent adults, who struggle to receive support. Attention deficit hyperactivity disorder (ADHD) and autism are the most common forms of neurodivergence. In the UK around 1 in every 20 children, and 3 in every 100 adults have ADHD and/or autism. Although there has been more understanding and awareness about autism and ADHD in recent years, many adults and children still don’t have a diagnosis. Without a diagnosis, it is impossible to access the care that they need.

Adults with undiagnosed ADHD or autism face many difficulties. For example, they are more likely to drop out of school, experience depression and anxiety, be involved in crimes, and have problems with drugs or alcohol. Early identification and effective support can reduce these difficulties. It is crucial to diagnose ADHD and autism as early as possible to reduce these long-term risks for adults with these conditions.

Currently, there is no research on the risks of not receiving an ADHD or autism diagnosis. However, this three-year project looks at the impacts of undiagnosed ADHD or autism on individuals and their families. It will also assess the economic and societal costs of undiagnosed ADHD and autism. This research will provide essential information to decision makers and healthcare providers, enabling them to improve access to care.

We have two main questions:

• What are the long-term risks of not diagnosing individuals with ADHD or autism?
• How much does the lack of diagnosis cost individuals, the community, and the economy?

We want to:

• Understand the risks and costs of not diagnosing ADHD or autism.
• Highlight the importance of early diagnosis for ADHD and autism.

To answer the questions of what are the long term risks associated with undiagnosed ADHD/ASD and what are the costs of these risks, the project includes two phases:

The first phase identified the risks associated with having undiagnosed ASD/ADHD, from a systematic review of the available evidence (Paper 1). Semi structured interviews will be conducted with undiagnosed/late diagnosed adults with ASD/ADHD and their families. Interviews will also be conducted with healthcare professionals to highlight the risks associated with late diagnosis.

The second phase will concentrate on establishing the economic costs of the identified risks associated with undiagnosed ASD/ADHD. Through an economic evaluation, the risks associated will be compared within three adult groups (childhood diagnosis, late diagnosis and undiagnosed)

A steering group will inform the project throughout its entire research cycle. A group of 10 adults with a late diagnosis of ADHD/ASD have agreed to feedback on different stages of the project to ensure we are capturing the experiences truly. The group will help the research team interpret findings from the systematic review, identify risks not explored in previous research and those risks which require further investigation in the qualitative study. It will assist in drafting an interview schedule prior to semi-structured interviews with late diagnosed adults affected by ADHD and/or autism and their families to identify the full range of potential risks associated with being undiagnosed with these conditions. And finally the group will assist with the economic evaluation questionnaire.

The risks associated with having ADHD umbrella review:

Our comprehensive review sheds light on the extensive ramifications of having ADHD, revealing mental health vulnerabilities, physical health risks, and societal implications, emphasizing the necessity of a holistic approach.

“Going Through Life on Hard Mode”—The Experience of Late Diagnosis of Autism and/or ADHD: A Qualitative Study

This qualitative study reflects on the experiences and impact of receiving a late diagnosis of ADHD or autism.

Five key themes were constructed from the analysis:

These findings reinforce the benefits that can come with early diagnosis, through understanding, finding a community, and better mental health. The study also highlights the potential drawbacks of this and can help adults, as well as health care professionals, understand the process of diagnosis and its potential impact (negative or positive).

After establishing the risks associated with undiagnosed Autism/ADHD, the second phase will focus on an economic evaluation to assess the individual and societal economic costs associated with these risks.

A survey will be conducted with 800 adults with ADHD or autism living in England. We will compare three groups: adults with undiagnosed ASD/ADHD, adults with ASD/ADHD diagnosed in childhood and adults with ASD/ADHD diagnosed in adulthood. The survey will enable the collection of data regarding outcomes, service use, diagnosis and participant demographic characteristics.